L-arginine binding to human inducible nitric oxide synthase: an antisymmetric funnel route toward isoform-specific inhibitors?

Nitric oxide (NO) is an important signaling molecule produced by a family of enzymes called nitric oxide synthases (NOS). Because NO is involved in various pathological conditions, the development of potent and isoform-selective NOS inhibitors is an important challenge. In the present study, the dimer of oxygenase domain of human iNOS (iNOSoxy) complexed to its natural substrate L-arginine (L-Arg) and both heme and tetrahydro-L-biopterin (BH4) cofactors was studied through multiple molecular dynamics simulations. Starting from the X-ray structure available for that complex (PDB: 1NSI ), a 16 ns equilibration trajectory was first obtained. Twelve dynamics of slow extraction of L-Arg out from the iNOSoxy active site were then performed. The steered molecular dynamics (SMD) approach was used starting from three different points of the reference trajectory for a total simulation time of 35 ns. A probable unbinding/binding pathway of L-Arg was characterized. It was suggested that a driving force directed the substrate toward the heme pocket. Key intermediate steps/residues along the access route to the active site were identified along this "funnel shape" pathway and compared to existing data. A quasi-normal mode analysis performed on the SMD data suggested that large collective motions of the protein may be involved in L-Arg binding and that opening the route to the active site in one monomer promoted an inverse, closing motion in the second monomer. Finally, our findings might help to rationalize the design of human iNOS isoform competitive inhibitors.     

Synthèse du mèthyl-1 diformyl-2,3 pyrrole,de la méthyl-1 pyrrolo[2,3-d] pyridazine et de la méthyl-1 oxo-6 (6h)cycloheptatrieno[b] pyrrole

This communication describes the synthesis of l-methyl-2,3-diformylpyrrole. This new compound is used to prepare a new heterocycle, l-methylcyclohepta[b]pyrrol-6-one and thus allows a new synthesis of l-methylpyrrolo[2,3-d]pyridazine.     

On-line preconcentration and determination of nickel in natural water samples by flow injection-inductively coupled plasma optical emission spectrometry (FI-ICP-OES)

An on-line nickel preconcentration and determination system implemented with inductively coupled plasma optical emission spectrometry (ICP-OES) associated to flow injection (FI) was studied. Trace amounts of nickel were preconcentrated by sorption on a conical minicolumn packed with activated carbon (AC) at pH 5.0. The nickel was removed from the minicolumn with 20% nitric acid. An enrichment factor of 80-fold for a sample volume of 50 ml was obtained. The detection limit (DL) value for the preconcentration method proposed was 82 ng l⁻¹. The precision for ten replicate determinations at the 0.5 μg l⁻¹ Ni level was 3.0% relative standard deviation (R.S.D.), calculated from the peak heights obtained. The calibration graph preconcentration method for nickel was linear with a correlation coefficient of 0.9997 at levels near the detection limits (DL) up to at least 100 μg l⁻¹. The method was successfully applied to the determination of nickel in natural water samples.     

Determination of promethazine hydrochloride with bromophenol blue by a turbidimetric method and flow injection analysis

A flow injection analysis procedure for the turbidimetric determination of promethazine is proposed. The sample solution is injected directly into the carrier reagent stream, which is composed of 1.16 × 10⁻³M bromophenol blue at pH 1.20. The calibration graph is linear over the range 25–197 ppm of promethazine. The influence of some foreign substances was also investigated. The method is applied to promethazine determination in a pharmaceutical formulation.     

on the existence of organometallic palladium(IV) complexes

The reactions of palladium(II) compounds of the type Cl₂PdL₂ with bromobis(pentafluorophenyl)thallium(III) has been reexamined. The reported preparation of the organo palladium(IV) complex Cl₂Pd(C₆F₅)₂(PPh₃)₂ could not be repeated, and instead mixtures of binuclear palladium(II) compounds, Cl₂Pd(C₆F₅)₂L₂, and mononuclear palladium(II) compounds were obtained. The binuclear are transformed into the mononuclear complexes on addition of an excess of ligand L.The chlorine bridging atoms of the binuclear complexes can be replaced by other halogens or pseudohalogens by treatment with salts of the MX type (X = Br, I, SCN).     

Synthesis of a new insoluble polymer-supported chiral alcohol auxiliary and its first application to nucleophilic addition to ketenes

The preparation of a new optically active alcohol with a carboxylic function that allowed its attachment to an amine-functionalized insoluble polymer is described. Its first use as a polymer supported chiral auxiliary is demonstrated by asymmetric transformation of two racemic aryl propionic acids via ketene formation (95-96% ee).     

Cloud point extraction of vanadium in parenteral solutions using a nonionic surfactant (PONPE 5.0) and determination by flow injection-inductively coupled plasma optical emission spectrometry

A preconcentration and determination methodology for vanadium at trace levels in parenteral solutions was developed. Cloud point extraction was successfully employed for the preconcentration of vanadium prior to inductively coupled plasma atomic optical emission spectrometry (ICP-OES) coupled to a flow injection (FI) system. The vanadium was extracted as vanadium-2-(5-bromo-2-pyridylazo)-5-diethylaminophenol [V-(5-Br-PADAP)] complex, at pH 3.7 mediated by micelles of the nonionic surfactant polyoxyethylene (5.0) nonylphenol (PONPE 5.0). The extracted surfactant-rich phase (100 mul) was mixed with 100 mul of ethanol and this final volume injected into ICP-OES for the vanadium determination. Under these conditions, the 50 ml sample solution preconcentration allowed raising an enrichment factor of 250-fold; however, it was possible to obtain a theoretical enrichment factor of 500-fold. The lower limit of detection (LOD) obtained under the optimal conditions was 16 ng l(-1). The precision for 10 replicate determinations at the 2.0 mug l(-1) V level was 2.3% relative standard deviation (RSD), calculated with the peak heights. The calibration graph using the preconcentration system for vanadium was linear with a correlation coefficient of 0.9996 at levels near the detection limits up to at least 50 mug l(-1). The method was successfully applied to the determination of vanadium in parenteral solution samples.     

X-ray diffraction and (1)H NMR in solution: structural determination of lanthanide complexes of a Py(2)N(6)Ac(4) ligand

Complexes between the Py(2)N(6)Ac(4) (H(4)L) ligand containing four carboxylate pendant arms and trivalent lanthanide ions have been synthesized, and structural studies have been made both in the solid state and aqueous solution. The crystal structures of the La, Ce, Sm, Tb, Dy, Ho, Er, Tm, and Lu complexes, with chemical formulas [LaH(2)L](NO(3)).3H(2)O (1), [Ce(4)L(2)](NO(3))(4).30H(2)O (2), [SmHL].EtOH.3H(2)O (5), [TbHL].EtOH.3H(2)O (8), [DyHL].2EtOH.2H(2)O (9), [HoHL].3H(2)O (10), [ErHL].EtOH.3H(2)O (11) [TmHL].EtOH.3H(2)O (12), and [LuHL].3H(2)O (14), have been determined by single-crystal X-ray crystallography. In the solid state, the complexes of the lighter lanthanide ions La(3+)-Dy(3+) show a 10-coordinated geometry close to a distorted bicapped antiprism, where the carboxylate pendants are situated alternatively above and below the best plane that contains the nitrogen donor atoms. The complexes of the heavier ions, Ho(3+)-Lu(3+), have a 9-coordinated geometry close to distorted tricapped trigonal prism, with one of the pendant carboxylate groups uncoordinated. The ligand is in a "twist-fold" conformation, where the twisting of the pyridine units is accompanied by an overall folding of the major ring of the macrocycle so that the pyridine nitrogen atoms and the metal are far from linear. The aqueous solution structures of the complexes were thoroughly characterized, the diamagnetic ones (La(3+) and Lu(3+)) by their COSY NMR spectra, and the paramagnetic complexes using a linear least-squares fitting of the (1)H LIS (lanthanide-induced shift) and LIR (lanthanide-induced relaxation) data with rhombic magnetic susceptibility tensors. The solution structures obtained for the La(3+)-Dy(3+) complexes (10-coordinate) and for the Tm(3+)-Lu(3+) complexes (9-coordinate) are in very good agreement with the corresponding crystal structures. However, the 10-coordinate structure is still exclusive in solution for the Ho(3+) complex and predominant for the Er(3+) complex.     

Investigation of block depth distribution in PS‐b‐PMMA block copolymer using ultra‐low‐energy cesium sputtering in ToF‐SIMS

Directed self‐assembly of block copolymers (BCPs) is a promising candidate for next generation nanolithography. In order to validate a given pattern, the lateral and in‐depth distributions of the blocks should be well characterized; for the latter, time‐of‐flight (ToF) SIMS is a particularly well‐adapted technique. Here, we use an ION‐TOF ToF‐SIMS V in negative mode to provide qualitative information on the in‐depth organization of polystyrene‐b‐polymethylmethacrylate (PS‐b‐PMMA) BCP thin films. Using low‐energy Cs⁺ sputtering and Bi₃⁺ as the analysis ions, PS and PMMA homopolymer films are first analyzed in order to identify the characteristic secondary ions for each block. PS‐b‐PMMA BCPs are then characterized showing that self‐assembled nanodomains are clearly observed after annealing. We also demonstrate that the ToF‐SIMS technique is able to distinguish between the different morphologies of BCP investigated in this work (lamellae, spheres or cylinders). ToF‐SIMS characterization on BCP is in good agreement with XPS analysis performed on the same samples. Copyright © 2013 John Wiley & Sons, Ltd.     

Biotransformation-mediated synthesis of (1S)-1-(2,6-dichloro-3-fluorophenyl)ethanol in enantiomerically pure form

An efficient four-step biotransformation-mediated synthesis of (1S)-1-(2,6-dichloro-3-fluorophenyl)ethanol in enantiomerically pure form is described. This compound is a key intermediate required for the preparation of PF-2341066, a potent inhibitor of c-Met/ALK that is currently in clinical development. The described synthesis was used to manufacture 6 kg of the title compound and can also be employed to produce the corresponding (1R)-enantiomer.